<DOC>
	<DOCNO>NCT00022373</DOCNO>
	<brief_summary>RATIONALE : Iseganan hydrochloride may effective prevent lessen oral mucositis patient receive radiation therapy head neck cancer . It yet know iseganan hydrochloride effective prevent oral mucositis . PURPOSE : Randomized phase III trial determine effectiveness iseganan hydrochloride prevent oral mucositis patient receive radiation therapy head neck cancer .</brief_summary>
	<brief_title>Iseganan Hydrochloride Preventing Oral Mucositis Patients Who Are Undergoing Radiation Therapy Head Neck Cancer</brief_title>
	<detailed_description>OBJECTIVES : I . Compare efficacy safety iseganan HCl oral solution v placebo patient undergo radiotherapy without chemotherapy head neck cancer . II . Compare effect treatment mouth pain , ability swallow , weight loss , distribution oral mucositis patient . OUTLINE : This randomize , double-blind , placebo-controlled , multicenter study . Patients stratify accord radiotherapy ( conventional fractionating radiotherapy v hyperfractionating concurrent boost radiotherapy ) concurrent chemotherapy ( yes v ) . Patients randomize 1 3 arm . Arm I : Patients rinse iseganan HCl oral solution 6 time daily . Treatment continue duration schedule radiotherapy . Arm II : Patients rinse oral placebo 6 time daily . Treatment continue duration schedule radiotherapy . Arm III : Patients receive standard-of-care supportive treatment . Oral cavity pain , ability swallow , weight loss assess twice weekly follow-up day 28 56 . Patients follow day 28 56 . PROJECTED ACCRUAL : A total 504 patient ( 252 arm I , 168 arm II , 84 arm III ) accrue study .</detailed_description>
	<mesh_term>Head Neck Neoplasms</mesh_term>
	<mesh_term>Mucositis</mesh_term>
	<mesh_term>Stomatitis</mesh_term>
	<mesh_term>Radiation Injuries</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically confirm malignancy head neck , include cancer oral cavity , oropharynx , nasopharynx , hypopharynx , salivary gland Undergoing plan undergo radiotherapy head neck involve : Bilateral treatment either conventional , hyperfractionated , concurrent boost external beam radiotherapy Minimum total radiation dose 60 Gy least 3 site within oral cavity Total schedule administration 8 week No oral mucositis already present Ulceration relate head neck malignancy prior surgery allow PATIENT CHARACTERISTICS : Age : 18 Performance status : Not specify Life expectancy : Not specify Hematopoietic : Not specify Hepatic : Not specify Renal : Not specify Other : Must able orally rinse study drug Not pregnant nursing Negative pregnancy test Fertile patient must use effective contraception PRIOR CONCURRENT THERAPY : Biologic therapy : Not specify Chemotherapy : Concurrent chemotherapy allow Endocrine therapy : No concurrent topical corticosteroid oral cavity Radiotherapy : See Disease Characteristics Surgery : See Disease Characteristics Other : At least 30 day since prior investigational agent prevention and/or treatment mucositis No prior participation study No concurrent topical anesthetic , lidocaine dyclonine hydrochloride , within 30 minute 15 minute study agent No concurrent oral rinse within 15 minute study agent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2001</verification_date>
	<keyword>stage I nasopharyngeal cancer</keyword>
	<keyword>stage II nasopharyngeal cancer</keyword>
	<keyword>stage III nasopharyngeal cancer</keyword>
	<keyword>stage IV nasopharyngeal cancer</keyword>
	<keyword>stage I salivary gland cancer</keyword>
	<keyword>stage II salivary gland cancer</keyword>
	<keyword>stage III salivary gland cancer</keyword>
	<keyword>stage IV salivary gland cancer</keyword>
	<keyword>recurrent salivary gland cancer</keyword>
	<keyword>untreated metastatic squamous neck cancer occult primary</keyword>
	<keyword>recurrent metastatic squamous neck cancer occult primary</keyword>
	<keyword>stage I lip oral cavity cancer</keyword>
	<keyword>stage II lip oral cavity cancer</keyword>
	<keyword>stage III lip oral cavity cancer</keyword>
	<keyword>stage IV lip oral cavity cancer</keyword>
	<keyword>stage I hypopharyngeal cancer</keyword>
	<keyword>stage II hypopharyngeal cancer</keyword>
	<keyword>stage III hypopharyngeal cancer</keyword>
	<keyword>stage IV hypopharyngeal cancer</keyword>
	<keyword>stage I oropharyngeal cancer</keyword>
	<keyword>stage II oropharyngeal cancer</keyword>
	<keyword>stage III oropharyngeal cancer</keyword>
	<keyword>stage IV oropharyngeal cancer</keyword>
	<keyword>radiation toxicity</keyword>
	<keyword>oral complication radiation therapy</keyword>
</DOC>